China STEMI-PCI Program

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2012 by Peking University First Hospital
Sponsor:
Collaborators:
Abbott Vascular
Sanofi
Information provided by (Responsible Party):
Yong Huo, Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT01716884
First received: October 26, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted
  Purpose
  1. Registration
  2. Performing in three stages
  3. Major aim: Much more and standard reperfusion therapy in STEMI patients

Condition
ST Segment Elevation Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: China STEMI-PCI Program

Further study details as provided by Peking University First Hospital:

Primary Outcome Measures:
  • The reperfusion ratio [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Door to Balloon time [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]
  • BMS ratio [ Time Frame: up to 1 day ] [ Designated as safety issue: No ]
  • health economic evaluation [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 4000
Study Start Date: December 2011
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

STEMI Patients enrolled and followed up 1 year

Criteria

Inclusion Criteria:

  • Onset of STEMI within 12h
  • Onset of STEMI within 12-36h needing primary PCI

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01716884

Contacts
Contact: Yan Zhang, MD 8610-83575180 drzhy1108@163.com

Locations
China
Division of Cardiology, Peking University First Hospital Recruiting
Beijing, China, 100034
Principal Investigator: Yong Huo, MD         
Sponsors and Collaborators
Peking University First Hospital
Abbott Vascular
Sanofi
  More Information

No publications provided

Responsible Party: Yong Huo, Director of cardiovascular department, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT01716884     History of Changes
Other Study ID Numbers: 2011[436]
Study First Received: October 26, 2012
Last Updated: October 26, 2012
Health Authority: China: Ministry of Health

Keywords provided by Peking University First Hospital:
STEMI
reperfution
primary PCI

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on September 16, 2014